An ovarian germ cell tumor is a growth in a woman's ovaries. Most of these tumors aren’t cancer. Instead, they are “benign” growths. Cancerous germ cell tumors are rare. They make up only 2% ...

In a study on ovarian cancer cells, researchers from Karolinska Institutet ... Ph.D. student at the Department of Oncology-Pathology, Karolinska Institutet, and the study's first author.

Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to ...

A New York Times story this week about tennis legend Chris Evert’s battle—twice—with ovarian cancer painted a simple and ...

How ovarian cancer disables immune cells Date: October 23, 2024 Source: Weill Cornell Medicine Summary: Researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and ...

[12] In conclusion, SLCT is a rare ovarian sex-cord tumor that usually occurs unilaterally. SLCT should always be considered in a young female patient who has symptoms of virilization and an ...

In particular, natural killer cells, are emerging as an optimal cell target for immunotherapy in ovarian cancer. Natural killer cells are a type of white blood cell responsible for eliminating ...

Two recent large studies profiling ovarian cancer vasculature make ovarian tumor vascular cells the best characterized to date. Tumor vascular-specific antigens have the potential to act as ...

The stage of a cancer tells you how far it has grown. For ovarian germ cell cancers, doctors use the same staging system that they use for other types of ovarian cancer. There are 4 stages, from 1 to ...

The closeness of this area to the omentum and peritoneum gives cancer cells a clear path to spread into the abdominal cavity. Cancer surgeons usually operate to stage and remove ovarian cancer at ...

called adaptive NK cells, to remember ovarian tumors and effectively attack them. The discovery, published in Cancer Immunology Research, could pave the way for new, more powerful immunotherapies for ...

"Discovering tumor-associated antigens that T cells recognize is crucial for the success of immunotherapeutic approaches in ovarian cancer, where the growth of cells that form in the ovaries ...